Snowball logo
logo
DVAX

Dynavax Technologies Corporation

DVAX β€’ NASDAQ
$15.50$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20202021202220232024TTM
Revenue
Total revenue
46.55439.4722.7232.3277.2330.5
COGS
13.91173.6262.250.1749.4555.62
Gross Profit
32.64265.9460.5182.1227.8274.9
Operating Expenses & Income
Operating Income
(75.22)134.5283.5(37.03)(4.122)10.44
Total Operating Expenses
107.9131.4177219.1231.9264.5
R&D Expenses
28.6132.2346.654.8961.5573.78
Selling General & Admin Expenses
79.26100.2131.4152.9170.4179.7
Earnings from Continuing Operations
Interest Expense
(19.06)(11.18)(6.732)(6.757)(6.794)(6.413)
Interest Income
1.260.147.91226.7636.4629.54
Income Tax Expense
16.540.8081.1432.0223.5462.79
Net Income
Net Income
(75.24)76.71293.2(6.389)27.31(43.4)
Supplemental
EBIT
(56.18)88.73012.3937.65(33.89)
EBITDA
(46.84)95.75307.79.66645.7(25.65)
In millions of USD, except % and values per 1 share